Evidence-based smoking cessation treatment within six months of a cancer diagnosis maximizes survival benefit, accordi ...

Ratios of visceral proteins can act as independent indicators for both overall and progression-free survival in patients with ...

In an interview with Targeted Oncology, Neal Shore, MD, FACS, discussed the background, findings, and implications of a ...

PROGNOSTIC value of specific visceral protein ratios in patients with colon cancer can offer healthcare professionals a novel approach to estimating progression-free survival (PFS) and overall ...

JMP Securities initiates coverage on Summit Therapeutics, citing promising data for ivonescimab in NSCLC and setting a $32 ...

A new study aimed to explore the role of stress hyperglycemia ratio (SHR) in predicting mortality risks for patients with ...

Restaging magnetic resonance imaging (MRI) can predict organ preservation and survival with rectal cancer, according to a ...

Maintaining good health and well-being is crucial for how well patients respond to cancer treatments. Unfortunately, cachexia ...

Patients in the induction chemotherapy group reported more frequent grade 3 or greater adverse events. Evidence Rating Level: ...

A recent study reveals that extended lymphadenectomy offers no survival advantage over standard lymphadenectomy for patients ...

Inavolisib plus palbociclib-fulvestrant yields significantly longer progression-free survival than placebo plus ...